About 5 results found for searched term "9012-76-4" (0.131 seconds)
Cat.No. | Name | Target |
---|---|---|
M9632 | Chitosan (MW 100000) | Cell Transfection |
Chitosan is a natural polycationic linear polysaccharide derived from chitin. | ||
M54726 | Chitosan (MW 150000) | Cell Transfection |
Deacetylated chitin (MW 150000); Poly(D-glucosamine) (MW 150000) | ||
Chitosan (MW 150000) is a polycationic linear polysaccharide derived from chitin with a molecular weight of 150000.Chitosan is non-toxic, hypoallergenic, biocompatible, biodegradable, and possesses anti-tumor, anti-bacterial, anti-fungal, and anti-oxidant activities.Chitosan can be used in studies related to drug delivery and cell transfection. | ||
M54725 | Chitosan (MW 30000) | Cell Transfection |
Deacetylated chitin (MW 30000); Poly(D-glucosamine) (MW 30000) | ||
Chitosan (MW 30000) is a polycationic linear polysaccharide derived from chitin with a molecular weight of 30,000.Chitosan is non-toxic, hypoallergenic, biocompatible, biodegradable, and possesses anti-tumor, anti-bacterial, anti-fungal, and antioxidant activities.Chitosan can be used in studies related to drug delivery and cell transfection. | ||
M58467 | Chitosan (≥95% deacetylated, MW 50000-60000) | Cell Transfection |
Chitosan (≥95% deacetylated, MW 50000-60000) is a polycationic linear polysaccharide derived from chitin .Chitosan is non-toxic, hypoallergenic, biocompatible, biodegradable, and possesses anti-tumor, anti-bacterial, anti-fungal, and antioxidant activities.Chitosan can be used in studies related to drug delivery and cell transfection. | ||
M2007 | Romidepsin (FK228) | HDAC |
FK228; ISTODAX; Depsipeptide; FR 901228; NSC 630176 | ||
Romidepsin (FK228, Depsipeptide, FR 901228, NSC 630176) is a structurally unique, potent HDAC1 and HDAC2 inhibitor with IC50 of 36 nM and 47 nM, respectively.*The compound is unstable in solutions, freshly prepared is recommended |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.